Lectin-like transcript 1 (LLT1) is a natural killer (NK) cell inhibitory ligand that has been described to contribute to the immunosuppressive properties of glioblastoma, prostate cancer, and triple negative breast cancer[6–9]. This evidence concerns the gene CLEC2D and triple-negative breast carcinoma.